Accepting the recommendations of the expert committee on vaccine administration, the union government on Monday asked the states and union territories to increase the interval between two doses of Covishield --- the Oxford-AstraZencea vaccine produced locally by Serum Institute of India --- to 4-8 weeks.
Keeping the existing scientific evidence in view, it appears that that the protection from coronavirus is enhanced if the second dose of Covishield is administered between 6-8 weeks, the government said.
However, it warned that the second dose of vaccine should not be administered after 8 weeks.
The interval between two doses of Covishield, has